We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$5.37B
AUM Growth
+$652M
Cap. Flow
+$278M
Cap. Flow %
5.18%
Top 10 Hldgs %
33.04%
Holding
214
New
23
Increased
122
Reduced
48
Closed
21

Top Buys

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$80.7M
2
GENI icon
Genius Sports
GENI
+$58.9M
3
ZETA icon
Zeta Global
ZETA
+$46.6M
4
MGNI icon
Magnite
MGNI
+$46.1M
5
BBBY
Bed Bath & Beyond
BBBY
+$43.9M

Top Sells

Rank Stock Value
1
KLIC icon
Kulicke & Soffa
KLIC
+$73.6M
2
ETSY icon
Etsy
ETSY
+$60.1M
3
DMYD
dMY Technology Group, Inc. II
DMYD
+$49.7M
4
CLDR
Cloudera, Inc.
CLDR
+$47.8M
5
SPT icon
Sprout Social
SPT
+$36.3M

Sector Composition

Rank Sector Weight
1 Technology 36.73%
2 Healthcare 17.37%
3 Industrials 15.63%
4 Consumer Discretionary 9.57%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VG
126
DELISTED
Vonage Holdings Corporation
VG
$8.12M 0.15%
563,218
+154,669
+38% +$2.11M
WNS
127
DELISTED
WNS Holdings
WNS
$8.04M 0.15%
100,640
+29,755
+42% +$2.21M
STNG icon
128
Scorpio Tankers
STNG
$3.83B
$7.9M 0.15%
358,373
-127,412
-26% -$2.59M
EDIT icon
129
Editas Medicine
EDIT
$432M
$7.83M 0.15%
138,266
+7,162
+5% +$265K
TDUP icon
130
ThredUp
TDUP
$424M
$7.66M 0.14%
+263,506
New +$5.68M
SPNS
131
DELISTED
Sapiens International
SPNS
$7.61M 0.14%
289,837
-385,837
-57% -$11.4M
CTSO icon
132
Cytosorbents Corp
CTSO
$22.7M
$7.58M 0.14%
1,003,546
+91,392
+10% +$770K
KPTI icon
133
Karyopharm Therapeutics
KPTI
$44.4M
$7.55M 0.14%
48,771
+2,744
+6% +$398K
DRNA
134
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7.52M 0.14%
+201,512
New +$6.18M
PRPL icon
135
Purple Innovation
PRPL
$39.6M
$7.5M 0.14%
11,358
+3,434
+43% +$2.64M
SMED
136
DELISTED
Sharps Compliance Corp
SMED
$7.3M 0.14%
709,157
-46,535
-6% -$648K
BCRX icon
137
BioCryst Pharmaceuticals
BCRX
$2.51B
$7.18M 0.13%
453,995
+24,093
+6% +$327K
SHSP
138
DELISTED
SharpSpring, Inc.
SHSP
$7.05M 0.13%
417,384
-77,352
-16% -$1.18M
ESPR
139
DELISTED
Esperion Therapeutics
ESPR
$7.04M 0.13%
333,085
+17,165
+5% +$413K
MGNX icon
140
MacroGenics
MGNX
$259M
$6.97M 0.13%
259,442
+14,165
+6% +$415K
RDWR icon
141
Radware
RDWR
$1.2B
$6.7M 0.12%
217,743
+75,119
+53% +$2.17M
PPLI
142
People Inc
PPLI
$3.03B
$6.65M 0.12%
52,595
-3,282
-6% -$425K
AXTI icon
143
AXT Inc
AXTI
$4.83B
$6.54M 0.12%
595,898
+196,888
+49% +$2.09M
ONTO icon
144
Onto Innovation
ONTO
$14.5B
$6.53M 0.12%
89,350
+29,442
+49% +$2.02M
PTC icon
145
PTC
PTC
$16.4B
$6.4M 0.12%
45,293
+14,968
+49% +$2.05M
EGIO
146
DELISTED
Edgio, Inc. Common Stock
EGIO
$5.86M 0.11%
46,484
+17,460
+60% +$2.3M
TTD icon
147
Trade Desk
TTD
$6.29B
$5.73M 0.11%
74,110
-11,560
-13% -$739K
PRTK
148
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.69M 0.11%
834,260
-23,318
-3% -$189K
BPMC
149
DELISTED
Blueprint Medicines
BPMC
$5.48M 0.1%
62,278
+3,371
+6% +$309K
RDUS
150
DELISTED
Radius Health, Inc.
RDUS
$5.44M 0.1%
+298,260
New +$5.93M
4 5
6
7 8

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Granahan Investment Management held 214 positions worth $5.37B, up 14% from $4.72B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management deployed $278M of net new capital in Q2 2021, opening 23 new positions and adding to 122 existing holdings. Its largest new stake was Genius Sports: 2,972,846 shares worth $55.8M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Kulicke & Soffa, an estimated $73.6M trimmed.

  • Granahan Investment Management's largest Q2 2021 buy was Genius Sports: 2,972,846 shares worth $55.8M.
  • Granahan Investment Management added most to Paycom in Q2 2021, an estimated $80.7M increase.
  • Granahan Investment Management's biggest Q2 2021 reduction was Kulicke & Soffa, cutting an estimated $73.6M.
  • Granahan Investment Management fully exited dMY Technology Group, Inc. II in Q2 2021, selling an estimated $49.7M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $5.37B portfolio in Q2 2021.
  • Granahan Investment Management opened 23 new positions and closed 21 in Q2 2021.
  • Granahan Investment Management's portfolio value rose 14% quarter-over-quarter to $5.37B.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.